Description

Flunarizine hydrochloride is a calcium channel blocker used in pharmacological research involving vascular regulation, neurological disorders, and migraine pathophysiology. It blocks the influx of calcium ions, reducing neuronal excitability and vasospasm in experimental models.

This product contains 5mg of flunarizine hydrochloride per capsule, and each box includes 17 capsules × 3 blisters. Manufactured by Dingfukang Pharmaceutical Co., Ltd., this compound is approved under NMPA H41024078 and intended strictly for laboratory and analytical research.

Note: Not for human or veterinary use. Laboratory research only.

Product Specifications

Mechanism of Action & Research Applications

Flunarizine is a selective calcium channel blocker with antihistamine properties. It reduces intracellular calcium overload by preventing the influx of calcium ions across cell membranes, making it relevant in research on:

• Migraine and vestibular disorders

• Epilepsy and seizure models

• Vascular smooth muscle contraction

• Cerebral ischemia and neuroprotection

• Calcium-related signal transduction in neurons

Known Research-Associated Side Effects

• Drowsiness

• Weight gain

• Extrapyramidal symptoms in long-term use

• Fatigue

• Gastrointestinal discomfort

Safety & Handling

Intended Use: For research use only. Not for human or veterinary applications.
Protective Equipment: Use gloves, lab coat, and safety goggles during handling.
Storage Instructions: Keep sealed at room temperature (<25°C), in a dry and dark environment.
Disposal: Dispose of in accordance with local chemical disposal regulations.

Research Use Disclaimer

This product is strictly intended for laboratory research use only. It is not for human or veterinary consumption, diagnosis, or treatment. Handle with appropriate safety measures. Misuse may result in legal or health consequences.